Evidence map›Paper›PMID 33566573›Full record

ArticleACS applied materials & interfaces2021

A Portable Magnetic Particle Spectrometer for Future Rapid and Wash-Free Bioassays.

Kai Wu, Vinit Kumar Chugh, Arturo di Girolamo, Jinming Liu, Renata Saha, Diqing Su, Venkatramana D Krishna, Abilash Nair, Will Davies, Yongqiang Andrew Wang and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS applied materials & interfaces, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Kai WuDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID http://orcid.org/0000-0002-9444-6112
Vinit Kumar ChughDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Arturo di GirolamoDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Jinming LiuDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID http://orcid.org/0000-0002-4313-5816
Renata SahaDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID http://orcid.org/0000-0002-0389-0083
Diqing SuDepartment of Chemical Engineering and Material Science, University of Minnesota, Minneapolis, Minnesota 55455, United States.ORCID http://orcid.org/0000-0002-5790-8744
Venkatramana D KrishnaDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, Minnesota 55108, United States.
Abilash NairDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Will DaviesDepartment of Computer Science, University of Minnesota, Minneapolis, Minnesota 55455, United States.
Yongqiang Andrew WangOcean Nano Tech LLC, San Diego, California 92126, United States.
Maxim C-J CheeranDepartment of Veterinary Population Medicine, University of Minnesota, St. Paul, Minnesota 55108, United States.
Jian-Ping WangDepartment of Electrical and Computer Engineering, University of Minnesota, Minneapolis, Minnesota 55455, United States.
University of Minnesota · USOcean NanoTech (United States) · US

Funding

A SARS-CoV-2 Breathalyzer for Direct Virus DetectionR42DE030832 · NIDCR · AEROSOL DEVICES, INC. · PI KEADY, PATRICIA BEA · 2021 to 2021
$254k
NIDCR NIH HHS R42 DE030832
6 · The paper itself

Abstract

Nowadays, there is an increasing demand for more accessible routine diagnostics for patients with respect to high accuracy, ease of use, and low cost. However, the quantitative and high accuracy bioassays in large hospitals and laboratories usually require trained technicians and equipment that is both bulky and expensive. In addition, the multistep bioassays and long turnaround time could severely affect the disease surveillance and control especially in pandemics such as influenza and COVID-19. In view of this, a portable, quantitative bioassay device will be valuable in regions with scarce medical resources and help relieve burden on local healthcare systems. Herein, we introduce the MagiCoil diagnostic device, an inexpensive, portable, quantitative, and rapid bioassay platform based on the magnetic particle spectrometer (MPS) technique. MPS detects the dynamic magnetic responses of magnetic nanoparticles (MNPs) and uses the harmonics from oscillating MNPs as metrics for sensitive and quantitative bioassays. This device does not require trained technicians to operate and employs a fully automatic, one-step, and wash-free assay with a user friendly smartphone interface. Using a streptavidin-biotin binding system as a model, we show that the detection limit of the current portable device for streptavidin is 64 nM (equal to 5.12 pmole). In addition, this MPS technique is very versatile and allows for the detection of different diseases just by changing the surface modifications on MNPs. Although MPS-based bioassays show high sensitivities as reported in many literatures, at the current stage, this portable device faces insufficient sensitivity and needs further improvements. It is foreseen that this kind of portable device can transform the multistep, laboratory-based bioassays to one-step field testing in nonclinical settings such as schools, homes, offices, etc.

Indexed as

Biological AssaySmartphoneCOVID-19HumansHydrodynamicsInfluenza, HumanMagnetic PhenomenaMagnetite NanoparticlesParticle SizeStreptavidinSurface PropertiesMagnetite NanoparticlesStreptavidinbioassaymagnetic particle spectrometerpoint-of-careportablewash-free

Identifiers

PMID33566573
PMCPMC9053107
OpenAlexW3127663419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.